Skip to content
Biodatica
Start free

Investigator

Wei-Qi Wei

VANDERBILT UNIVERSITY MEDICAL CENTER · funded by NIA, NHLBI, NICHD

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.0M

Summed across those awards.

First award
Sep 10, 2021

Latest Jan 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias

    $852k

    Jan 1, 2025NIAVANDERBILT UNIVERSITY MEDICAL CENTERNIH RePORTER · 11251781 (opens the source filing in a new tab)

  2. R01

    Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data

    $862k

    Jul 15, 2024NHLBIVANDERBILT UNIVERSITY MEDICAL CENTERNIH RePORTER · 11138582 (opens the source filing in a new tab)

  3. P50

    Phenotyping Support Core

    $242k

    Sep 10, 2021NICHDVANDERBILT UNIVERSITY MEDICAL CENTERNIH RePORTER · 11170766 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources